Not many people are really able to keep things under tight wraps. Certainly, many a jailbird might be able to or the occasional secret agent perhaps, but at the latest when it comes to grandpas and grandmas, best friends or any typical gossips, information leaks are everywhere. Even in Hillary Clinton’s administration, much to the enjoyment of Wikileaks. However, in Düsseldorf a branch of trade is currently presenting leak-free products, guaranteed for 50 years. If only everyone were able to do what the valves on display at the Valve World Expo are capable of.
The University of Texas Health Science Center at Houston (UTHealth) has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child’s own umbilical cord blood stem cells for traumatic brain injury in children. The study is being performed in conjunction with Children’s Memorial Hermann Hospital, UTHealth’s primary children’s teaching hospital.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cordblood/48021/
The Substance Abuse and Mental Health Services Administration (SAMHSA) in collaboration with the Ad Council today expanded efforts to continue to provide information, support and resources to individuals and families affected by the Deepwater Horizon oil spill. Emotional distress resulting from traumatic events can surface years after an incident occurs.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/48177/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Millions of U.S. drivers are putting themselves at risk and wasting fuel by failing to properly check tire pressure, according to a new survey by the Rubber Manufacturers Association (RMA).
Only 15 percent of motorists revealed that they know how to correctly check tire pressure. Under inflated tires contribute to more than 600 highway fatalities and 33,000 thousand injuries each year, according to the National Highway Traffic Safety Administration (NHTSA). Additionally, under inflated tires cause U.S. drivers to waste 1.2 billion gallons of fuel annually.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/rma/50200/
“The smallest moments can have the biggest impact on a child’s life. Take time to be a dad today.” That’s the campaign message of new public service advertisements (PSAs) launching today nationwide in recognition of Father’s Day. According to the U.S. Census Bureau, an estimated 24 million children (34%) in the U.S. live apart from their fathers. The PSA campaign is an effort between the U.S. Department of Health and Human Services’ (HHS) Administration for Children and Families, Office of Family Assistance and the Ad Council to show fathers the unique and irreplaceable role they play in their children’s lives.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/50580/
The Ad Council is joining the U.S. Department of Agriculture’s Food Safety and Inspection Service, in partnership with the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), to debut their first joint national multimedia public service campaign to help families prevent food poisoning in the home.
The Food Safe Families campaign was announced this morning by USDA Secretary Tom Vilsack and HHS Secretary Kathleen Sebelius in time for the July 4th holiday and the start of summer when foodborne illnesses tend to increase—a time when many families celebrate with food. It’s also a time when foodborne illnesses tend to increase with more outdoor meals, and other factors that increase the risk for disease-causing bacteria in food.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/50582/
ADP®, a leading provider of human resource outsourcing, payroll, tax, business outsourcing and benefits administration services, and integrated computing solutions for vehicle dealers, today announced the launch of ALINE Pay by ADPSM, a comprehensive electronic payroll disbursement solution that helps employers reduce administration time and minimize their risk of financial and compliance exposure. The ALINE Pay electronic pay solution is designed to be compliant in all 50 states through a new innovative wage funding and distribution solution and gives both employers and employees flexibility in choosing the method of payment that best meets their needs: ADP Full Service Direct Deposit, the new ALINE Card by ADPSM or ALINE Check by ADPSM.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51192-adp-aline-pay-electronic-payroll-compliance-solution
The U.S. Food and Drug Administration (FDA) Office of Women’s Health today released a new public service announcement (PSA) titled, “Use Medicines Wisely,” to help raise awareness about safe medication use.
Millions of people benefit from FDA approved medications and are living longer productive lives. However, when medications are used incorrectly, they can cause serious injuries, even death. Many of these injuries can be prevented.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/fda/50878/
More than 26,000 preteens (children ages 8 – 12) are available for adoption from the U.S. foster care system, according to the Administration for Children and Families Adoption and Foster Care Analysis Report System (AFCARS). To promote the adoption of preteens from the U.S. foster care system, the U.S. Department of Health and Human Services’ (HHS) Administration for Children and Families (ACF), AdoptUSKids (AUSK) and the Ad Council today unveiled a new series of national public service advertisements (PSAs). Created pro bono by kirshenbaum bond senecal + partners (kbs+p) and Revolución, the PSAs will be distributed this week as part of National Adoption Month.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52724-ad-council-adoptuskids-hhs-preteens-for-adoption-from-foster-care
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43510-boston-scientific-fda-promus-element-plus-platinum-chromium-stent-system
